Angiontensin(1-7)

血管紧张素II（1-7）

Report date: 2025/03/13 10:24:15
NME

Base Information

Drug NameAngiontensin(1-7)
Drug Alias NameAngiotensin 1-7 [A(1-7)]Angiotensin Peptide (1-7)TalfirastideAng-(1-7)Ang(1-7) +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin II receptor agonists
TargetsAngiotensin II receptor
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Ischemic StrokeCognition Disorders +[36] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesBrazilIsrael
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesTarix Orphan
China Registration ClassN/A

Develop Information

Active CompaniesNational Institutes Of HealthThe University Of ArizonaColumbia University +[7] 
Inactive CompaniesUS Biotest IncWake Forest University Health SciencesStanford University +[5] 
Active IndicationsCoronavirus Disease 2019 (COVID-19)Ischemic StrokeHealthy Aging +[11] 
Inactive IndicationsCognition DisordersMetabolic DiseasesLymphopenia +[25] 

Other Information

ATC CodeN/A
Related LinksN/A